By InvitationNot Applicable

The Novel Special Light for Endotracheal/Bronchial Lesions.

China400 participantsStarted 2024-01-31

Plain-language summary

This is a single-center study. The purpose of this study is o evaluate the diagnostic value of special light (TXI, NBI, RDI) in endotracheal/bronchial lesions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥18 years old;
✓. Patients with chest imaging findings indicating central lung lesions requiring further bronchoscopy;
✓. Patients with neoplasm in the lumen that could be biopsied by bronchoscopy or operated;
✓. Patient who has good compliance and sign informed consent;
✓. The investigator believes that the subjects can understand the process of the clinical study, are willing and able to complete all the research procedures and follow-up visits, and cooperate with the research procedures.

Exclusion criteria

✕. Pregnant or lactating women;
✕. No endotracheal/bronchial lesions were detected by bronchoscopy;
✕. Allergic reaction to narcotic drugs in previous medical history;
✕. The investigator believes that the subject is not suitable for bronchoscopy;
✕. High-risk diseases or other special conditions for which the investigator considers the subjects unsuitable for clinical trials.

What they're measuring

Diagnostic accuracy of the special light for endotracheal/bronchial Lesions.

Timeframe: 1month

Trial details

NCT IDNCT07036614

SponsorShanghai Chest Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-09-30

View on ClinicalTrials.gov More Tracheal Disease trials